Patent · US Active

Use of oligomers of lactic acid in the treatment of gynaecological disorders

US9315444B2 · kind B2 · utility

0Cited by

5References

20Claims

0Family size

Assignee

LACCURE AB · SE

Inventors

Greg Batcheller · Brussels, BE
Thomas Hedner · Gällstad, SE
Joergen Johnsson · Helsingborg, SE
Werner Schubert · Mölndal, SE
Christer Sjoegren · Viken, SE
Olov Sterner · Eidsvold, AU
Malgorzat Sznitowska · Gdańsk, PL

Key dates

Filing date	Jun 20, 2014
Grant date	Apr 19, 2016
Priority date	—
Expiry date	Jun 20, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of one or more oligomers of lactic acid or a lactic acid oligomeric product for the prophylaxis and/or treatment of a disease or condition that benefits from an acidic environment, especially a gynaecological infection including a bacterial infection such as bacterial vaginosis, unspecific colpitis, senile colpitis, cervicitis, and urethritis, a fungal infection, such as candidosis (Candida albicans), cryptococcosis, actinomycosis, or a viral infection, such as Human Immunodefiency Virus (HIV), Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.